ADVANCED BREAST CARCINOMA
Clinical trials for ADVANCED BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Drug-Resistant breast cancer: experimental combo shows promise
Disease control OngoingThis study tests a new drug (TVB-2640) combined with standard therapies in people with HER2-positive breast cancer that has spread and stopped responding to treatment. The goal is to see if this combination can shrink tumors or slow the disease. The trial involves 17 adults with …
Matched conditions: ADVANCED BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 04:14 UTC
-
New drug combo targets tough cancers in early trial
Disease control OngoingThis early-phase trial tests a new drug (BAY 1895344) combined with standard chemotherapy in people with advanced solid tumors, especially bladder cancer. The goal is to find the safest dose and see how well the combination works. About 74 adults with cancers like lung, bladder, …
Matched conditions: ADVANCED BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo therapy targets hard-to-treat HER2 cancers in early trial
Disease control OngoingThis early-phase trial tests a combination of two drugs—trastuzumab deruxtecan (a targeted chemotherapy) and ceralasertib (a cell-growth blocker)—in people with advanced solid tumors that have a HER2 mutation. The study first finds the safest dose, then compares the combo against…
Matched conditions: ADVANCED BREAST CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 06, 2026 16:02 UTC